PREVENTION AND TREATMENT OF GASTROINTESTINAL TRACT MUCOSITIS DURING THERAPY INCLUDING 5-FLUORURACIL
The main component in the schemes of adjuvant chemotherapy in the treatment of colorectal cancer is 5- fluorouracil, which has a high gastrointestinal toxicity. With its use, the incidence of adverse events from the stomach and intestines is about 30-40%. The lack of generally accepted principles for the prevention and treatment of these complications determines the relevance of the problem in the clinical practice of a doctor.